# Molecular Characterization of Advanced Stage Melanoma by Blood Sampling

> **NCT02862743** · NA · COMPLETED · sponsor: **CHU de Reims** · enrollment: 50 (actual)

## Conditions studied

- Metastatic Melanoma

## Interventions

- **OTHER:** patients with metastatic melanoma

## Key facts

- **NCT ID:** NCT02862743
- **Lead sponsor:** CHU de Reims
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-14
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02862743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02862743, "Molecular Characterization of Advanced Stage Melanoma by Blood Sampling". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02862743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*